QNTM QUANTUM BIOPHAR
QUANTUM BIOPHAR (QNTM) is expected to report earnings on November 12, 2026, before the market open.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About QUANTUM BIOPHAR
Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Quantum BioPharma, formerly known as FSD Pharma Inc., is based in Toronto, Ontario.
Charts powered in part by Lightweight Charts™ by TradingView.